Status:
COMPLETED
A Pilot Study Using Facebook to Support Opioid Recovery Among American Indian Women
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opioid use.
Detailed Description
This one-year, Phase I, pilot preparatory study aims to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opio...
Eligibility Criteria
Inclusion
- Inclusion Criteria - Phase 1:
- AIAN Women:
- AIAN based on self-reported race.
- Gender identity as a woman.
- Resides in Minnesota.
- At least 18 years of age age with no upper age limit.
- OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013).
- Self-reports at least one month of opioid abstinence based on Timeline Follow-Back (TLFB) interview.
- Currently receiving MOUD.
- Is comfortable speaking and reading English.
- Is familiar with Facebook.
- Has access to broadband internet on a mobile phone/computer/tablet at any location.
- AI/AN Health Care Providers and Stakeholders
- Health care provider or AIAN community stakeholder.
- Knowledge of Native culture and/or OUD treatment and recovery among AIAN people.
- Is comfortable speaking and reading English.
- Is familiar with Facebook.
- Has access to broadband internet on a mobile phone/computer/tablet at any location.
- Having some familiarity with the Facebook platform is needed to provide feedback on content for a Facebook intervention. Access to the internet is needed to view online moderator postings for providing feedback during the interview.
- Inclusion Criteria - Phase 3:
- AIAN person based on self-reported race/ethnicity.
- Gender identity as a woman.
- At least 18 years of age.
- Resides in Minnesota.
- OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013).
- Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen.
- Currently receiving MOUD.
- Is comfortable speaking and reading English.
- Has an existing Facebook account or willing to set one up.
- Is willing and able to participate in the Facebook intervention for one month.
- Has access to broadband internet on a mobile phone/computer/tablet at any location.
- Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS.
- Exclusion Criteria:
- AIAN potential participants in Phases 1 and 3 meeting any of the exclusion criteria listed below will be excluded from study participation. Community stakeholder participants in - Phase 1 will only fail the screening if they meet the second exclusion criterion:
- Self-reports current suicidality.
- Inability or unwillingness of participant to provide verbal consent (Phase 1) or written informed consent (Phase 3).
- (Phase 3 only) Was a participant in Phase 1.
- Pregnant women, lactating women, or women who plan to become pregnant will not be excluded because the treatment being evaluated is a behavioral intervention and does not involve medication or risk to the fetus.
Exclusion
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 8 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05340855
Start Date
May 5 2022
End Date
June 8 2023
Last Update
June 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905